Sodium-retaining effect of insulin in diabetes

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 303, Issue 11, 2012, Pages

  Brands, Michael W ^a   Marlina Manhiani, M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Diabetes; Diuresis; Insulin; Natriuresis; Sodium balance

Indexed keywords

ALLOXAN; INSULIN; SODIUM;

CONTINUOUS INFUSION; DIABETES MELLITUS; DIURESIS; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN INFUSION; KIDNEY FUNCTION; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NATRIURESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SODIUM RETENTION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; SODIUM;

EID: 84870569716     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00390.2012     Document Type: Review

References (98)

1. Ackermann TF, Boini KM, Volkl H, Bhandaru M, Bareiss PM, Just L, Vallon V, Amann K, Kuhl D, Feng Y, Hammes HP, Lang F. SGK1-sensitive renal tubular glucose reabsorption in diabetes. Am J Physiol Renal Physiol 296: F859-F866, 2009.
2. Ahmed MI, Calhoun DA. Resistant hypertension: bad and getting worse. Hypertension 57: 1045-1046, 2011.
3. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246-2252, 1991.
4. Atchley DW, Loeb RF, Richards DW, Benedict EM, Driscoll ME. On diabetic acidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest 12: 297-326, 1933.
5. Baquero AF, Gilbertson TA. Insulin activates epithelial sodium channel (ENaC) via phosphoinositide 3-kinase in mammalian taste receptor cells. Am J Physiol Cell Physiol 300: C860-C871, 2011.
6. Bardgett ME, McCarthy JJ, Stocker SD. Glutamatergic receptor activation in the rostral ventrolateral medulla mediates the sympathoexcitatory response to hyperinsulinemia. Hypertension 55: 284-290, 2010.
7. Barrett EJ. The endocrine pancreas. In: Medical Physiology, edited by Boron WF, and Boulpaep EL. Philadelphia, PA: Elsevier Saunders, 2005, p. 1066-1085.
8. Berglund G, Larsson B, Andersson O, Larsson O, Svardsudd K, Bjorntorp P, Wilhelmsen L. Body composition and glucose metabolism in hypertensive middle-aged males. Acta Med Scand 200: 163-169, 1976.
9. Blantz RC, Tucker BJ, Gushwa L, Peterson OW. Mechanism of diuresis following acute modest hyperglycemia in the rat. Am J Physiol Renal Fluid Electrolyte Physiol 244: F185-F194, 1983.
10. Blazer-Yost BL, Esterman MA, Vlahos CJ. Insulin-stimulated trafficking of ENaC in renal cells requires PI 3-kinase activity. Am J Physiol Cell Physiol 284: C1645-C1653, 2003.
11. Blazer-Yost BL, Liu X, Helman SI. Hormonal regulation of ENaCs: insulin and aldosterone. Am J Physiol Cell Physiol 274: C1373-C1379, 1998.
12. Blazer-Yost BL, Nofziger C. The role of the phosphoinositide pathway in hormonal regulation of the epithelial sodium channel. Adv Exp Med Biol 559: 359-368, 2004.
13. Brands MW, Bell TD, Rodriquez NA, Polavarapu P, Panteleyev D. Chronic glucose infusion causes sustained increases in tubular sodium reabsorption and renal blood flow in dogs. Am J Physiol Regul Integr Comp Physiol 296: R265-R271, 2009.
14. Brands MW, Fitzgerald SM. Chronic intravenous glucose infusion causes moderate hypertension in rats. Am J Hypertens 13: 99-102, 2000.
15. Brands MW, Hailman AE, Fitzgerald SM. Long-term glucose infusion increases arterial pressure in dogs with cyclooxygenase-2 inhibition. Hypertension 37: 733-738, 2001.
16. Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system. Hypertension 29: 1014-1019, 1997.
17. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive. Hypertension 19: I83-I89, 1992.
18. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol Regul Integr Comp Physiol 260: R764-R768, 1991.
19. Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin hypertension in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 271: R276-R281, 1996.
20. Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs. Am J Hypertens 4: 164-168, 1991.
21. Briet M, Schiffrin EL. The role of aldosterone in the metabolic syndrome. Curr Hypertens Rep 13: 163-172, 2011.
22. Brown NJ. This is not Dr. Conn's aldosterone anymore. Trans Am Clin Climatol Assoc 122: 229-243, 2010.
23. + channel (ENaC) hormones, hypertension. J Biol Chem 285: 23527-23531, 2010.
24. Catena C, Cavarape A, Novello M, Giacchetti G, Sechi LA. Insulin receptors and renal sodium handling in hypertensive fructose-fed rats. Kidney Int 64: 2163-2171, 2003.
25. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 96: 2514-2519, 1999.
26. Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension: a review. Circulation 39: 403-421, 1969.
27. Claxton CR, Brands MW, Fitzgerald SM, Cameron JA. Inhibition of nitric oxide synthesis potentiates hypertension during chronic glucose infusion in rats. Hypertension 35: 451-456, 2000.
28. DeFronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia 21: 165-171, 1981.
29. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 55: 845-855, 1975.
30. DeFronzo RA, Goldberg M, Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 58: 83-90, 1976.
31. Friedberg CE, van Buren M, Bijlsma JA, Koomans HA. Insulin increases sodium reabsorption in diluting segment in humans: evidence for indirect mediation through hypokalemia. Kidney Int 40: 251-256, 1991.
32. Fujita N, Baba T, Tomiyama T, Kodama T, Kako N. Hyperinsulinaemia and blood pressure in patients with insulinoma. BMJ 304: 1157, 1992.
33. + exchanger. Am J Physiol Renal Fluid Electrolyte Physiol 258: F514-F521, 1990.
34. + exchange activity in proximal tubules from normotensive and hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 260: F695-F703, 1991.
35. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
36. Guyton AC, Coleman TG, Cowley AV, Scheel KW, Manning RD, Norman RA. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52: 584-594, 1972.
37. Guyton AC, Hall JE. Textbook of Medical Physiology. Philadelphia, PA: Elsevier Saunders, 2006.
38. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA, Gaillard CA. Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines? Hypertension 15: 519-527, 1990.
39. Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia does not cause hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 260: F663-F669, 1991.
40. Hall JE, Brands MW, Zappe DH, Dixon WN, Mizelle HL, Reinhart GA, Hildebrandt DA. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin-resistant dogs. Hypertension 25: 994-1002, 1995.
41. Hall JE, Coleman TG, Mizelle HL, Smith MJJ. Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol Renal Fluid Electrolyte Physiol 258: F722-F731, 1990.
42. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, Smith G, Stec DE. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 285: 17271-17276, 2010.
43. Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension. Kidney Int Suppl 55: S35-S41, 1996.
44. Hills CE, Bland R, Bennett J, Ronco PM, Squires PE. High glucose up-regulates ENaC and SGK1 expression in HCD-cells. Cell Physiol Biochem 18: 337-346, 2006.
45. Hills CE, Squires PE, Bland R. Serum and glucocorticoid regulated kinase and disturbed renal sodium transport in diabetes. J Endocrinol 199: 343-349, 2008.
46. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512-516, 1987.
47. Jansen PM, Danser JA, Spiering W, van den Meiracker AH. Drug mechanisms to help in managing resistant hypertension in obesity. Curr Hypertens Rep 12: 220-225, 2010.
48. Jansen PM, Verdonk K, Imholz BP, Jan Danser AH, van den Meiracker AH. Long-term use of aldosterone-receptor antagonists in uncontrolled hypertension: a retrospective analysis. Int J Hypertens 2011: 1-12, 2011.
49. Keen HL, Brands MW, Alonso-Galicia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats. Am J Hypertens 9: 1192-1199, 1996.
50. Keen HL, Brands MW, Smith MJ Jr, Hall JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats. Hypertension 31: 637-642, 1998.
51. Keen HL, Brands MW, Smith MJ Jr, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin hypertension in rats. Am J Hypertens 10: 1125-1131, 1997.
52. Kirchner KA. Insulin increases loop segment chloride reabsorption in the euglycemic rat. Am J Physiol Renal Fluid Electrolyte Physiol 255: F1206-F1213, 1988.
53. Kirk EP, Klein S. Pathogenesis and pathophysiology of the cardiometabolic syndrome. J Clin Hypertens (Greenwich) 11: 761-765, 2009.
54. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity. J Clin Invest 65: 1272-1284, 1980.
55. Koopmans SJ, Ohman L, Haywood JR, Mandarino LJ, DeFronzo RA. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in normal rats. Diabetes 46: 1572-1578, 1997.
56. Kurukulasuriya LR, Stas S, Lastra G, Manrique C, Sowers JR. Hypertension in obesity. Med Clin North Am 95: 903-917, 2011.
57. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum-and glucocorticoid-inducible kinase isoforms. Physiol Rev 86: 1151-1178, 2006.
58. + channels by aldosterone: role of Sgk1. Clin Exp Pharmacol Physiol 35: 235-241, 2008.
59. Liang CS, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB. Insulin infusion in conscious dogs. J Clin Invest 69: 1321-1336, 1982.
60. Loffing J, Korbmacher C. Regulated sodium transport in the renal connecting tubule (CNT) via the epithelial sodium channel (ENaC). Pflügers Arch 458: 111-135, 2009.
61. Manhiani MM, Cormican MT, Brands MW. Chronic sodium-retaining action of insulin in diabetic dogs. Am J Physiol Renal Physiol 300: F957-F965, 2011.
62. Manhiani MM, Duggan AD, Wilson H, Brands MW. Chronic intrarenal insulin replacement reverses diabetes mellitus-induced natriuresis and diuresis. Hypertension 59: 421-430, 2012.
63. Maric C, Hall JE. Obesity, metabolic syndrome and diabetic nephropathy. Contrib Nephrol 170: 28-35, 2011.
64. Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl 120: S1-S6, 2011.
65. Meehan WP, Buchanan TA, Hsueh W. Chronic insulin administration elevates blood pressure in rats. Hypertension 23: 1012-1017, 1994.
66. Miller JH, Bogdonoff MD. Antidiuresis associated with administration of insulin. J Appl Physiol 6: 509-512, 1954.
67. Mozaffari MS, Roysommuti S, Wyss JM. Contribution of the sympathetic nervous sytem to hypertensive response to insulin excess in spontaneously hypertensive rats. J Cardiol Pharmacol 27: 539-544, 1996.
68. Muntzel MS, Anderson EA, Johnson AK, Mark AL. Mechanisms of insulin action on sympathetic nerve activity. Clin Exp Hypertens 17: 39-50, 1995.
69. Pavlov TS, Imig JD, Staruschenko A. Regulation of ENaC-mediated sodium reabsorption by peroxisome proliferator-activated receptors. PPAR Res: Article ID 703735, 2010.
70. Pereda SA, Eckstein JW, Abboud FM. Cardiavascular responses to insulin in the absence of hypoglycemia. Am J Physiol 202: 249-252, 1962.
71. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 57: 1076-1080, 2011.
72. Pimenta E, Calhoun DA. Treatment of resistant hypertension. J Hypertens 28: 2194-2195, 2010.
73. Pontiroli AE, Alberetto M, Pozza G. Patients with insulinoma show insulin resistance in the absence of arterial hypertension. Diabetologia 35: 294-295, 1992.
74. Putnam K, Shoemaker R, Yiannikouris F, Cassis LA. The reninangiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am J Physiol Heart Circ Physiol 302: H1219-H1230, 2012.
75. Reaven GM, Ho H, Hoffman BB. Somatostatin inhibition of fructoseinduced hypertension. Hypertension 14: 117-120, 1989.
76. Record RD, Johnson M, Lee S, Blazer-Yost BL. Aldosterone and insulin stimulate amiloride-sensitive sodium transport in A6 cells by additive mechanisms. Am J Physiol Cell Physiol 271: C1079-C1084, 1996.
77. Ritz E. Metabolic syndrome and kidney disease. Blood Purif 26: 59-62, 2008.
78. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30: 219-225, 1981.
79. Saad S, Stevens VA, Wassef L, Poronnik P, Kelly DJ, Gilbert RE, Pollock CA. High glucose transactivates the EGF receptor and upregulates serum glucocorticoid kinase in the proximal tubule. Kidney Int 68: 985-997, 2005.
80. Sarafidis PA, Bakris GL. The antinatriuretic effect of insulin: an unappreciated mechanism for hypertension associated with insulin resistance? Am J Nephrol 27: 44-54, 2007.
81. Saudek CD, Boulter PR, Knopp RH, Arky RA. Sodium retention accompanying insulin treatment of diabetes mellitus. Diabetes 23: 240-246, 1974.
82. + channel: from amphibians to mammals. Gen Comp Endocrinol 147: 85-92, 2006.
83. Shibata H, Itoh H. Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension. Am J Hypertens 25: 514-523, 2012.
84. Sims EA, Danforth E Jr, Horton ES, Bray GA, Glennon JA, Salans LB. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res 29: 457-496, 1973.
85. Song J, Hu X, Riazi S, Tiwari S, Wade JB, Ecelbarger CA. Regulation of blood pressure, the epithelial sodium channel (ENaC), and other key renal sodium transporters by chronic insulin infusion in rats. Am J Physiol Renal Physiol 290: F1055-F1064, 2006.
86. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA 240: 1607-1610, 1978.
87. Stenvinkel P, Bolinder J, Alvestrand A. Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia 35: 1042-1048, 1992.
88. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364-2373, 2011.
89. Tirosh A, Garg R, Adler GK. Mineralocorticoid receptor antagonists and the metabolic syndrome. Curr Hypertens Rep 12: 252-257, 2010.
90. Tiwari S, Sharma N, Gill PS, Igarashi P, Kahn CR, Wade JB, Ecelbarger CM. Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor. Proc Natl Acad Sci USA 105: 6469-6474, 2008.
91. Toto RD, Seldin DW. Salt wastage. In: The Kidney, Physiology and Pathophysiology, edited by Seldin DW, and Giebisch G. Philadelphia, PA: Williams & Wilkins, 2000, p. 1519-1536.
92. Tsutsu N, Nunoi K, Kodama T, Nomiyama R, Iwase M, Fujishima M. Lack of association between blood pressure and insulin in patients with insulinoma. J Hypertens 8: 479-482, 1990.
93. Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: a tubulo-centric view. J Am Soc Nephrol 14: 530-537, 2003.
94. Vallon V, Sharma K. Sodium-glucose transport: role in diabetes mellitus and potential clinical implications. Curr Opin Nephrol Hypertens 19: 425-431, 2010.
95. Wang J, Barbry P, Maiyar AC, Rozansky DJ, Bhargava A, Leong M, Firestone GL, Pearce D. SGK integrates insulin and mineralocorticoid regulation of epithelial sodium transport. Am J Physiol Renal Physiol 280: F303-F313, 2001.
96. Ward KR, Bardgett JF, Wolfgang L, Stocker SD. Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 57: 435-441, 2011.
97. Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics in hyperglycemia: possible role of tubuloglomerular feedback. Am J Physiol Renal Fluid Electrolyte Physiol 252: F65-F71, 1987.
98. Zheng Y, Yamada H, Sakamoto K, Horita S, Kunimi M, Endo Y, Li Y, Tobe K, Terauchi Y, Kadowaki T, Seki G, Fujita T. Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption. J Am Soc Nephrol 16: 2288-2295, 2005.